arginine has been researched along with Lymphoma in 67 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (53.73) | 18.7374 |
| 1990's | 11 (16.42) | 18.2507 |
| 2000's | 10 (14.93) | 29.6817 |
| 2010's | 8 (11.94) | 24.3611 |
| 2020's | 2 (2.99) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, JN; Bao, Y; Bartlett, JR; Bissonnette, S; Briant, AR; Carcel, C; Chan, K; Chen, H; Chen, L; Cheng, C; Chrétien, M; Conway Fitzgerald, A; Cyr, Y; Du, Y; El-Sayed, YY; Endo, T; Faraj, M; Fujimoto, K; Girsen, A; Goto, H; Hashimoto, D; Hayasaka, K; Hayase, E; Herrmann, N; Hidaka, D; Holst, JJ; Igbinosa, I; Iijima, H; Jeandidier, N; Jeong, DY; Jeong, GT; Joubert, M; Kagawa, I; Kahata, K; Kaushik, LK; Kim, SK; Kim, SR; Kuang, Y; Laird, M; Lamantia, V; Li, P; Li, Y; Li, Z; Lindsay, SE; Liu, X; Loizon, E; Lu, Z; Lyell, DJ; Ma, J; Magnani, CJ; Mahalingam, AK; Mandal, N; Mayer, G; Michimata, R; Ngo Sock, ET; Okada, K; Onozawa, M; Opigez, V; Palanisamy, M; Parienti, JJ; Park, YR; Pavlikova, B; Peyro Saint Paul, L; Ramsahye, N; Reyes, GA; Reznik, Y; Richardson, MT; Samo, IA; Sarkar, R; Shendge, AK; Shimizu, C; Shiratori, S; Steinberg, JR; Sugita, J; Sukwong, P; Sun, X; Sunagoya, K; Sunwoo, IY; Svendsen, B; Tang, L; Tang, Z; Teshima, T; Totée, C; Turner, BE; Unno, M; Vidal, H; Wang, C; Wang, M; Wang, S; Wang, X; Wang, Z; Wassef, H; Weeks, BT; Wong Chi Man, M; Xu, C; Xu, W; Yamamoto, S; Yu, H; Zhang, WY; Zhang, X; Zhong, Y | 1 |
| Abedi-Valugerdi, M; Hassan, M; Madjidzadeh, K; Shariatpanahi, SP | 1 |
| Liu, J; Liu, XL; Shu, XL; Zhong, JX | 1 |
| Chitnis, N; Diehl, JA; Kita, Y; Klein-Szanto, AJ; Li, Y; Li, Z; Nakagawa, H; Natsugoe, S; Rustgi, AK; Wasik, M; Yang, Y | 1 |
| Darzy, KH; Shalet, SM; Thorner, MO | 1 |
| Bozzola, M; Buzi, F; Crinò, A; De Toni, T; Gargantini, L; Grugni, G; Meazza, C; Pagani, S; Pilotta, A; Pozzan, GB; Radetti, G; Ragusa, L; Salvatoni, A; Sartorio, A | 1 |
| Bomalaski, J; Cerio, R; Chen, LT; Crook, T; Delage, B; Fitzgibbon, J; Gribben, J; Hatzimichael, E; Joel, S; Lemoine, N; Li, CF; Luong, P; Maharaj, L; Mitchell, TJ; O'Riain, C; Papoudou-Bai, A; Syed, N; Szlosarek, PW; Whittaker, SJ | 1 |
| Cvetkovic, G; Evans, CH; Modiano, JF; O'Brien, TD; Rütgen, BC; Scott, MC; Tepic, S; Wells, JW | 1 |
| Foss, FM; Gorgun, G; Shao, RH; Tian, X; Urbano, AG | 1 |
| Arnold, RE; Weigent, DA | 1 |
| KRAEMER, PM | 1 |
| Brousse, N; Canioni, D; Damotte, D; Faller, DV; Ghez, D; Hermine, O; Lefrère, F; Perrine, SP; Varet, B | 1 |
| Askin, M; Boulad, F; Di Nicola, M; Faller, DV; Fingeroth, J; Gianni, AM; Hermine, O; Horwitz, S; Klein, C; Levy, A; Mentzer, SJ; O'Reilly, R; Perrine, SP; Small, T; Suarez, F | 1 |
| Cerutti, I; Chany, C; Mace, B | 1 |
| Bruchovsky, N; Gout, PW; Rennie, PS; Tze, WJ | 1 |
| Kumar, A; Singh, SM | 1 |
| Dietert, RR; Sung, YJ | 1 |
| Baron, C; Chan, JS; Filep, JG; Lachance, S; Perreault, C | 1 |
| Erbeznik, H; Hersh, LB | 1 |
| Boudreau, RT; Dodd, F; Limoges, M; Murphy, PR; Rowden, G; Too, CK | 1 |
| Boudreau, RT; Dodd, F; Limoges, M; Murphy, PR; Too, CK | 1 |
| Carter, KB; Cauthron, RD; Gan, J; Steinberg, RA; Zhang, YL | 1 |
| Gola, A; Kuliszkiewicz-Janus, M | 1 |
| Pryme, IF | 1 |
| Ryoyama, K | 1 |
| Daly, JM; Naji, A; Reynolds, JV; Shou, J; Sigal, R; Ziegler, MM | 1 |
| Hersh, EM | 1 |
| Bao, H; Cao, B; Cen, X; Gao, Y; Liang, R; Liu, A; Qin, Y; Shi, Y; Wang, J; Wang, N; Xie, Y; Xue, M; Yang, Y; Zhang, H; Zhang, L; Zhang, M; Zhang, Q; Zhang, W; Zhao, Y; Zhong, K | 1 |
| Chang, Y; Duan, L; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Tian, L; Wang, X; Wu, J; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X | 1 |
| Chang, Y; Fu, XR; Han, LJ; Li, L; Li, X; Ma, W; Sun, ZC; Wang, XH; Wu, JJ; Zhang, L; Zhang, MZ; Zhang, XD | 1 |
| Fickers, M; Haaxma-Reiche, H; Hansen, M; Kluin-Nelemans, HC; Poortmans, PM; Rozewicz, C; Soubeyran, P; Taphoorn, M; Teodorovic, I; Thomas, J; Van den Bent, M; van Glabbeke, M; Van Imhoff, G; Van't Veer, M | 1 |
| Li, HL; Sun, BZ; Wang, H | 1 |
| Aneja, R; Dong, X; Gao, J; Joshi, HC; Liu, M; Vangapandu, SN; Yates, C; Zhou, B; Zhou, J | 1 |
| Donner, L; Klener, P | 1 |
| Archimbaud, E; Blanc, M; Bryon, PA; Coiffier, B; Felman, P; Ffrench, M; Fière, D; Guyotat, D; Rebattu, P; Vuvan, H | 1 |
| Burgers, JM; Quasim, MM; Somers, R; van Glabbekke, M | 1 |
| Płuzańska, A; Robak, T | 1 |
| Carbone, A; Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, M; Tumolo, S; Veronesi, A; Volpe, R | 1 |
| Alonso, MT; Leyland-Jones, B; Marsoni, S; O'Dwyer, PJ | 1 |
| Anderson, J; Bennett, JM; Berard, CW; Brodovsky, HS; Glick, JH; Merrill, JM; Neiman, RS; O'Connell, MJ | 1 |
| Carbone, A; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Tumolo, S; Veronesi, A; Volpe, R | 1 |
| Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vialushkin, VIa | 1 |
| Straus, DJ; Warrell, RP; Young, CW | 1 |
| Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vygovskaia, IaI | 1 |
| Furuta, H; Miyabe, K; Miyaguchi, M; Sakai, S; Takeda, J; Uozumi, N | 1 |
| Muggia, FM | 1 |
| Sullivan, MP; Sutow, WW | 1 |
| Bunn, PA; Ihde, DC; Radice, PA | 1 |
| Le Bourgeois, JP | 1 |
| Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
| Charron, D; Dumonchel, P; Jorry, F; Laurens, A; Martola, R; Thevenot, J | 1 |
| Begg, CB; Bennett, JM; Brodovsky, HS; Carbone, PP; Chiuten, DF; Creech, RH; Falkson, G; Glick, J; Muggia, FM | 1 |
| Brunet, R; Chauvergne, J; De Mascarel, A; Durand, M; Hoerni, B; Hoerni-Simon, G; Lagarde, C; Meugé, C; Richaud, P | 1 |
| Duménil, D; Frindel, E; Sainteny, F | 1 |
| Sonneveld, P | 1 |
| Carbone, A; Monfardini, S; Sorio, R; Tirelli, U; Zagonel, V | 1 |
| Archimbaud, E; Berger, F; Bryon, PA; Coiffier, B; Extra, JM; Ffrench, M; Fiere, D; Gentilhomme, O; Guyotat, D; Magaud, JP | 1 |
| Civatte, J; Flageul, B; Iskandar, MJ; Maillet, M; Moulonguet, I; Perrin, P; Verola, O | 1 |
| Cooper, IA; Ding, JC; Griffiths, JD; Stark, RJ | 1 |
| Burgers, JM; Carde, P; Cosset, JM; Somers, R; Tubiana, M; Van Glabbeke, M | 1 |
| Abromowitch, M; Evans, WE; Hayes, FA; Rivera, GK; Rodman, JH; Sinkule, JA | 1 |
| Bakemeier, R; Glick, J; Grossberg, H; Muggia, F; Opfell, R; Schnetzer, G | 1 |
| Amiel, JL; Carde, P; Cosset, JM; Habrand, JL; Hayat, M; Henry-Amar, M; Ozanne, F; Tubiana, M | 1 |
| Abromowitch, M; Dahl, GV; Kalwinsky, DK; Look, AT; Mirro, J; Murphy, SB; Ochs, J; Pui, CH; Rivera, G | 1 |
| Abromowitch, M; Green, AA; Hayes, FA | 1 |
6 review(s) available for arginine and Lymphoma
| Article | Year |
|---|---|
Immunosuppression by L-asparaginase and related enzymes.
Topics: Animals; Arginine; Asparaginase; Glutaminase; Graft Rejection; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunosuppressive Agents; In Vitro Techniques; L-Serine Dehydratase; Leukemia; Lymphocyte Activation; Lymphoid Tissue; Lymphoma; Mice; Rabbits; Transplantation, Homologous | 1971 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
Teniposide: overview of its therapeutic potential in adult cancers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Etoposide; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma, Kaposi; Teniposide | 1994 |
VM 26 and VP 16-213: a comparative analysis.
Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1977 |
Teniposide in lymphomas and leukemias.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Humans; Leukemia; Lymphoma; Teniposide | 1992 |
Prognostic factors in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Prednisone; Prognosis; Teniposide; Vincristine | 1986 |
17 trial(s) available for arginine and Lymphoma
| Article | Year |
|---|---|
Topics: Adipose Tissue, White; Adult; Aged; Air Pollutants; Animals; Anti-Inflammatory Agents; Arginine; bcl-2-Associated X Protein; Biofuels; Biological Products; Blood Glucose; Breast Neoplasms; Caspases; CD36 Antigens; Cell Communication; Cell Proliferation; Cell Survival; Cooking; Cross-Sectional Studies; Databases, Factual; Diabetes Mellitus, Type 2; Diphtheria Toxin; Double-Blind Method; Exenatide; Extracellular Polymeric Substance Matrix; Feasibility Studies; Female; Filgrastim; Fruit; Galactose; Gene Deletion; Gene Knockdown Techniques; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Glucose; Glycated Hemoglobin; Hematopoietic Stem Cell Mobilization; Household Articles; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Lung; Lymphoma; Male; Metals, Heavy; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nanoparticles; Neoplasms; Obesity; Obstetrics; Odds Ratio; Oxygen; Peripheral Blood Stem Cell Transplantation; Photochemotherapy; Plant Extracts; Polyethylene Glycols; Polyglutamic Acid; Porosity; Postprandial Period; Prospective Studies; Quality of Life; Receptors, Glucagon; Receptors, LDL; Receptors, Somatostatin; Registries; Rhodophyta; Rhodotorula; Risk Factors; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Signal Transduction; Somatostatin; Stilbenes; Terminalia; Treatment Outcome; United States; Venoms | 2021 |
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arginine; Butyrates; Child; Child, Preschool; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Ganciclovir; Humans; Lymphoma; Male; Middle Aged | 2007 |
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Proto-Oncogene Proteins c-bcl-6; Teniposide; Treatment Outcome; Young Adult | 2018 |
High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome | 2003 |
Report on the EORTC lymphoma trial 20751.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Europe; Humans; Lymphoma; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Teniposide; Vincristine | 1983 |
[New antineoplastic drugs of the podophyllotoxin derivative group].
Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1983 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas.
Topics: Adult; Altretamine; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hematopoietic System; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin; Prednisone; Prospective Studies; Random Allocation; Teniposide | 1982 |
[Use of preparation VM 26 (epipodophyllotoxin) for treating lymphomas in children and adults].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Hodgkin Disease; Humans; Infant; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Podophyllotoxin; Teniposide; Time Factors | 1981 |
Combination chemotherapy for patients with relapsed malignant lymphoma using methyl-GAG and teniposide (VM-26).
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Guanidines; Humans; Lymphoma; Mitoguazone; Podophyllotoxin; Teniposide | 1982 |
Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hematologic Diseases; Humans; Kidney Diseases; Lymphoma; Podophyllotoxin; Prednisolone; Teniposide; Vincristine | 1982 |
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Topics: Alopecia; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Evaluation; Etoposide; Humans; Leukemia; Leukopenia; Lung Neoplasms; Lymphoma; Podophyllotoxin; Teniposide | 1979 |
[O.E.R.T.C. study on the treatment of non-Hodgkin's lymphomas: origin-aims-means (author's transl)].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Prednisone; Teniposide | 1977 |
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
Topics: Adult; Aged; Blood Cell Count; Clinical Trials as Topic; Drug Evaluation; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin; Teniposide | 1979 |
[Induction chemotherapy of non-Hodgkin malignant lymphomas. Results of a controlled trial comparing two quadruple associations (author's transl)].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Teniposide; Vincristine | 1978 |
Investigation of the additive potential of teniposide and vincristine in non-Hodgkin's lymphoma. Australian and New Zealand Lymphoma Group.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Middle Aged; Neoplasm Staging; Prednisolone; Random Allocation; Teniposide; Vincristine | 1986 |
Prognostic factors in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Prednisone; Prognosis; Teniposide; Vincristine | 1986 |
46 other study(ies) available for arginine and Lymphoma
| Article | Year |
|---|---|
Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.
Topics: Algorithms; Animals; Antineoplastic Agents; Arginine; Fluorouracil; Humans; Immune Tolerance; Immunity; Killer Cells, Natural; Lymphoma; Mice; Models, Immunological; Myeloid-Derived Suppressor Cells; Neoplasms; T-Lymphocytes, Cytotoxic | 2018 |
L-arginine enhances arginine deiminase induced human lymphoma cell growth inhibition through NF-kBp65 and p53 expression in vitro.
Topics: Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Hydrolases; Lymphoma; NF-kappa B; Nitric Oxide; Tumor Suppressor Protein p53 | 2014 |
PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Substitution; Animals; Apoptosis; Arginine; Cell Transformation, Neoplastic; Cluster Analysis; Cyclin D1; Cyclin-Dependent Kinase 4; Enzyme Activation; Gene Expression Profiling; Humans; Leukemia, T-Cell; Lymphoma; Lymphoma, T-Cell; Methylation; Mice; Mutation; Oncogenes; Phosphorylation; Protein-Arginine N-Methyltransferases; Tumor Suppressor Protein p53 | 2015 |
Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
Topics: Adolescent; Adult; Arginine; Brain Neoplasms; Case-Control Studies; Female; Follow-Up Studies; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin; Insulin-Like Growth Factor I; Leukemia; Lymphoma; Male; Middle Aged; Radiotherapy; Young Adult | 2009 |
Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome.
Topics: Adolescent; Arginine; Body Mass Index; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Female; Fluoroimmunoassay; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Lymphoma; Male; Obesity; Prader-Willi Syndrome; Prolactin; Reproducibility of Results; Secretory Rate | 2011 |
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis.
Topics: Apoptosis; Arginine; Argininosuccinate Synthase; Autophagy; Caspases; Chloroquine; DNA Methylation; Humans; Hydrolases; Lymphoma; Lymphoma, T-Cell, Cutaneous; Microtubule-Associated Proteins; Polyethylene Glycols; Promoter Regions, Genetic; Tumor Cells, Cultured | 2012 |
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
Topics: Adult Stem Cells; Animals; Antineoplastic Agents; Apoptosis; Arginase; Arginine; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Culture Media; Dogs; Leukemia; Lymphoma; Osteosarcoma | 2013 |
Arginine butyrate increases the cytotoxicity of DAB(389)IL-2 in leukemia and lymphoma cells by upregulation of IL-2Rbeta gene.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arginine; Butyrates; Cell Survival; Cyclic AMP; Diphtheria Toxin; Dose-Response Relationship, Drug; Drug Synergism; Humans; Interleukin-2; Interleukin-2 Receptor beta Subunit; Leukemia; Lymphoma; Receptors, Interleukin; Receptors, Interleukin-2; Recombinant Fusion Proteins; Response Elements; Second Messenger Systems; Up-Regulation | 2002 |
The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone.
Topics: Animals; Arginine; Carbocyanines; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance; Growth Hormone; Immune System; Lymphocytes; Lymphoma; Membrane Potentials; Methyl Methanesulfonate; Mice; Mitochondria; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Transport; Receptors, Somatotropin; Stress, Physiological | 2003 |
INTERACTION OF MYCOPLASMA (PPLO) AND MURINE LYMPHOMA CELL CULTURES: PREVENTION OF CELL LYSIS BY ARGININE.
Topics: Animals; Antineoplastic Agents; Arginine; Cell Biology; Cell Culture Techniques; Lymphoma; Mice; Mycoplasma; Pharmacology; Research; Tissue Culture Techniques | 1964 |
Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arginine; Butyrates; Chemical and Drug Induced Liver Injury; Disease Progression; Fas Ligand Protein; Fatal Outcome; Female; Ganciclovir; Humans; Killer Cells, Natural; Lymphoma; Membrane Glycoproteins; Middle Aged; Severity of Illness Index; Tumor Necrosis Factors | 2006 |
Effect of coordinated therapeutic assays using C. parvum, interferon and arginine butyrate on spontaneous disease and survival of AKR mice.
Topics: Animals; Arginine; Butyrates; Female; Interferons; Killer Cells, Natural; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred AKR; Propionibacterium acnes | 1983 |
Bioassay and radioimmunoassay of lactogens in sera from children.
Topics: Adolescent; Animals; Arginine; Biological Assay; Cells, Cultured; Child; Child, Preschool; Female; Growth Hormone; Humans; Infant; Insulin; Lymphoma; Male; Pituitary Gland; Prolactin; Radioimmunoassay; Rats | 1984 |
Effect of Dalton's lymphoma on the antigen presentation of murine peritoneal macrophages.
Topics: Animals; Antigen Presentation; Arginine; Cisplatin; Culture Media; Female; Lipopolysaccharides; Lymphoma; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C3H; Thymidine; Tritium; Uridine | 1995 |
Nitric oxide (.NO)-induced mitochondrial injury among chicken .NO-generating and target leukocytes.
Topics: Animals; Arginine; Cell Line; Cell Survival; Chickens; Hypoxanthines; Leukocytes; Lipopolysaccharides; Lymphoma; Macrophages; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidoreductases; Tumor Cells, Cultured | 1994 |
Involvement of nitric oxide in target-cell lysis and DNA fragmentation induced by murine natural killer cells.
Topics: Animals; Apoptosis; Arginine; Calmodulin; Cytotoxicity, Immunologic; DNA Damage; DNA, Neoplasm; Enzyme Inhibitors; Killer Cells, Natural; Lymphoma; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Sulfonamides; Tumor Cells, Cultured | 1996 |
A novel mammalian high-molecular-weight aminopeptidase.
Topics: Alanine; Amides; Aminopeptidases; Arginine; Brain; Chromatography, Gel; Enzyme Inhibitors; Humans; Immune Sera; Isoenzymes; Kinetics; Leucine; Lymphoma; Molecular Weight; Peptides; Puromycin; Spleen; Substrate Specificity; Tumor Cells, Cultured | 1997 |
L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells.
Topics: Animals; Apoptosis; Arginine; Blotting, Western; Cell Division; Dose-Response Relationship, Drug; Endothelium; In Situ Nick-End Labeling; Lipopolysaccharides; Lymphoma; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphorylation; Precipitin Tests; Prolactin; Protein Isoforms; Proto-Oncogene Proteins c-bcl-2; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Up-Regulation | 2000 |
Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells.
Topics: Animals; Apoptosis; Arginine; Cell Division; Fibroblast Growth Factor 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Lymphoma; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Prolactin; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
On the spontaneous mutability of CpG sites in cultured S49 mouse lymphoma cells.
Topics: 5-Methylcytosine; Animals; Arginine; Azacitidine; Cytosine; Dinucleoside Phosphates; DNA Methylation; DNA, Neoplasm; Hypoxanthine Phosphoribosyltransferase; Lymphoma; Mice; Mutagenesis; Tumor Cells, Cultured | 1999 |
[Value of arginine-glucose preparation in the prevention of hyperammonemia in patients treated with L-asparaginase].
Topics: Ammonia; Arginine; Asparaginase; Glucose; Humans; Leukemia, Lymphoid; Lymphoma | 1979 |
The effects of orally administered L-arginine HCl on the development of myeloma tumors in BABL/C mice following the injection of single cell suspensions, cell aggregates or tumor fragments; and on the growth of two ascites tumour cell lines.
Topics: Administration, Oral; Animals; Arginine; Carcinoma, Krebs 2; Cell Aggregation; Cell Communication; Cell Count; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Multiple Myeloma; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Isogeneic | 1978 |
Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamide.
Topics: Animals; Arginine; Cell Adhesion; Cell Division; Culture Media; Cyclophosphamide; Immunity, Cellular; In Vitro Techniques; Lymphoma; Macrophage Activation; Macrophages; Mice; Nitric Oxide; Nitrites; Picibanil; Tumor Cells, Cultured | 1992 |
Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts.
Topics: Animals; Arginine; Cytotoxicity, Immunologic; Diet; Dose-Response Relationship, Drug; Glycine; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Activation; Lymphoma; Macrophages; Male; Mice; Mice, Inbred Strains; Neuroblastoma | 1990 |
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Induction Chemotherapy; Lymphoma; Methotrexate; Retrospective Studies; Teniposide | 2023 |
Fotemustine, teniposide and dexamethasone in treating patients with CNS lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Radiotherapy, Adjuvant; Teniposide; Young Adult | 2014 |
[Survivin antisense oligonucleotide induces lymphoma cells apoptosis and sensitizes the cells to chemotherapy].
Topics: Apoptosis; Cell Line, Tumor; Humans; Inhibitor of Apoptosis Proteins; Lymphoma; Microtubule-Associated Proteins; Neoplasm Proteins; Oligonucleotides, Antisense; Survivin; Teniposide | 2004 |
Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dioxoles; Gene Expression Regulation, Neoplastic; Isoquinolines; Lymphoma; Mice; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Protein Binding; Teniposide; Tubulin | 2008 |
Therapy of non-Hodgkin's lymphomas in relapse.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Imidazoles; Lymphoma; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Splenectomy; Teniposide; Vincristine | 1980 |
[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma; Male; Prednisolone; Prednisone; Prognosis; Teniposide; Thioguanine; Vincristine | 1983 |
A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Topics: Adult; Age Factors; Aged; Asthenia; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1984 |
VM26 in malignant hematological diseases. A phase II study.
Topics: Drug Evaluation; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma; Podophyllotoxin; Teniposide | 1982 |
[Use of VM 26 (epipodophyllotoxin) in treating acute leukemias and lymphomas in the adult].
Topics: Acute Disease; Adult; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lymphoma; Podophyllotoxin; Teniposide; Time Factors | 1981 |
[Appropriate administration of granulocyte colony stimulating factor for malignant lymphoma of the head and neck].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Leukopenia; Lymphoma; Methotrexate; Prednisone; Teniposide; Vincristine | 1993 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Nitrogen Mustard Compounds; Osteosarcoma; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Rhabdomyosarcoma; Teniposide; Thioguanine; Vincristine; Wilms Tumor | 1976 |
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Prednisone; Teniposide | 1977 |
Some effects of chemotherapeutic drugs on bone marrow stem cells. II. Effect on non-Hodgkin lymphoma chemotherapy on various hemopoietic compartments of the mouse.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Colony-Forming Units Assay; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematopoietic Stem Cells; Leukocyte Count; Lymphoma; Male; Methylprednisolone; Mice; Mice, Inbred CBA; Models, Biological; Prednisone; Teniposide | 1979 |
Phase II study of teniposide (VM26) in cutaneous T-cell lymphomas.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Lymphoma; Male; Middle Aged; Mycosis Fungoides; Podophyllotoxin; Prognosis; Remission Induction; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes; Teniposide | 1990 |
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Teniposide; Vincristine | 1986 |
[Ki-1 large cell lymphoma with secondary xanthomatous infiltration of the lesions by chemotherapy].
Topics: Aged; Aged, 80 and over; Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Cyclophosphamide; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma; Male; Neck; Prednisone; Skin Neoplasms; Teniposide; Xanthomatosis | 1989 |
Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine.
Topics: Action Potentials; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Drug Synergism; Female; Humans; Lymphoma; Male; Middle Aged; Muscle Contraction; Neural Conduction; Peripheral Nervous System Diseases; Pilot Projects; Teniposide; Vincristine | 1986 |
Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
Topics: Child; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, Parenteral; Kinetics; Leukemia; Lymphoma; Neuroblastoma; Podophyllotoxin; Teniposide | 1987 |
Treatment of advanced refractory lymphoma with teniposide and lomustine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lomustine; Lymphoma; Male; Middle Aged; Teniposide | 1987 |
An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Teniposide; Time Factors | 1985 |
A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine.
Topics: Adolescent; Child; Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Injections, Spinal; Lymphoma; Male; Methotrexate; Podophyllotoxin; Prognosis; Teniposide; Thymus Gland | 1985 |
Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
Topics: Child; Child, Preschool; Diphenhydramine; Drug Hypersensitivity; Humans; Leukemia, Lymphoid; Lymphoma; Neuroblastoma; Podophyllotoxin; Teniposide | 1985 |